{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:09:34Z","timestamp":1791504574843,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1124\/dmd.119.087684","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T23:55:24Z","timestamp":1562111724000},"page":"954-960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics"],"prefix":"10.1016","volume":"47","author":[{"given":"Lenka","family":"Tupova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ceckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"Ambrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Sorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Ptackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Gaborik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantisek","family":"Staud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1124\/dmd.119.087684_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2125.2008.03133.x","article-title":"Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers","volume":"65","author":"Abel","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1124\/dmd.119.087684_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2125.2008.03137.x","article-title":"Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects","volume":"65","author":"Abel","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.119.087684_bib3","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/jac\/dkt095","article-title":"Transplacental passage of etravirine and maraviroc in a multidrug-experienced HIV-infected woman failing on darunavir-based HAART in late pregnancy","volume":"68","author":"Calcagno","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/dmd.119.087684_bib4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.reprotox.2006.01.007","article-title":"P-glycoprotein in the placenta: expression, localization, regulation and function","volume":"22","author":"Ceckova-Novotna","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1124\/dmd.119.087684_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.bcp.2015.08.099","article-title":"Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro","volume":"98","author":"Cihalova","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.087684_bib6","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/cid\/civ587","article-title":"Maraviroc pharmacokinetics in HIV-1-infected pregnant women","volume":"61","author":"Colbers","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1124\/dmd.119.087684_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/019262302753559614","article-title":"Pregnancy dating in the rat: placental morphology and maternal blood parameters","volume":"30","author":"de Rijk","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1124\/dmd.119.087684_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.119.087684_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/03602532.2010.512293","article-title":"Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy","volume":"43","author":"Hahnova-Cygalova","year":"2011","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.119.087684_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17425255.2018.1499726","article-title":"An update on expression and function of P-gp\/ABCB1 and BCRP\/ABCG2 in the placenta and fetus","volume":"14","author":"Han","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.119.087684_bib11","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1476-5381.2010.00801.x","article-title":"Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport","volume":"160","author":"Kuteykin-Teplyakov","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.119.087684_bib12","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1124\/dmd.112.048298","article-title":"Cytochrome P450 3A5 plays a prominent role in the oxidative metabolism of the anti-human immunodeficiency virus drug maraviroc","volume":"40","author":"Lu","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087684_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.coph.2006.01.009","article-title":"Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer","volume":"6","author":"Modok","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/dmd.119.087684_bib14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1517\/17425255.2010.514264","article-title":"ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison","volume":"6","author":"Myllynen","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.119.087684_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/QAD.0000000000000112","article-title":"Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta","volume":"28","author":"Neumanova","year":"2014","journal-title":"AIDS"},{"key":"10.1124\/dmd.119.087684_bib17","unstructured":"Office of AIDS Research Advisory Council (OARAC), Panel on Antiretroviral Guidelines for Adults and Adolescents (2019a) Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf."},{"key":"10.1124\/dmd.119.087684_bib18","unstructured":"Office of AIDS Research Advisory Council (OARAC), Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (2019b) Guidelines for the use of antiretroviral agents in pediatric HIV infection. http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/pediatricguidelines.pdf."},{"key":"10.1124\/dmd.119.087684_bib16","unstructured":"Office of AIDS Research Advisory Council (OARAC), Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission (2018) Recommendations for use of antiretroviral drugs in transmission in the United States. http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/PerinatalGL.pdf."},{"key":"10.1124\/dmd.119.087684_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12032-015-0607-x","article-title":"CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells","volume":"32","author":"Pervaiz","year":"2015","journal-title":"Med Oncol"},{"key":"10.1124\/dmd.119.087684_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13402-018-0415-3","article-title":"CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer","volume":"42","author":"Pervaiz","year":"2019","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1124\/dmd.119.087684_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2018.04.013","article-title":"Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro","volume":"154","author":"Sorf","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.087684_bib22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/1061186X.2012.716847","article-title":"Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure","volume":"20","author":"Staud","year":"2012","journal-title":"J Drug Target"},{"key":"10.1124\/dmd.119.087684_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.106.105023","article-title":"Expression and transport activity of breast cancer resistance protein (Bcrp\/Abcg2) in dually perfused rat placenta and HRP-1 cell line","volume":"319","author":"Staud","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.087684_bib24","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.jcim.8b00624","article-title":"Probing the pharmacological binding sites of P-glycoprotein using umbrella sampling simulations","volume":"59","author":"Subramanian","year":"2019","journal-title":"J Chem Inf Model"},{"key":"10.1124\/dmd.119.087684_bib25","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1128\/AAC.01821-12","article-title":"Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression","volume":"57","author":"Vinot","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.119.087684_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/dmd.104.002626","article-title":"Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV","volume":"33","author":"Walker","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.087684_bib27","first-page":"5447","article-title":"Maraviroc: a review of its use in HIV infection and beyond","volume":"9","author":"Woollard","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1124\/dmd.119.087684_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/jac\/dkq501","article-title":"Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro","volume":"66","author":"Zembruski","year":"2011","journal-title":"J Antimicrob Chemother"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624079467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624079467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.119.087684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:49:38Z","timestamp":1740055778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624079467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0090955624079467"],"URL":"https:\/\/doi.org\/10.1124\/dmd.119.087684","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between Maraviroc and the ABCB1, ABCG2, and ABCC2 Transporters: An Important Role in Transplacental Pharmacokinetics","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.119.087684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}